Cancer surveillance series: Recent rends in childhood cancer incidence and mortality in the United States

Journal of the National Cancer Institute

Volumn 91, Issue 12, 1999, Pages 1051-1058

  Linet, Martha S ^a,b   Ries, Lynn A G ^a   Smith, Malcolm A ^a   Tarone, Robert E ^a   Devesa, Susan S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DERMATOFIBROSARCOMA PROTUBERANS; HODGKIN DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; RETINOBLASTOMA; UNITED STATES;

EID: 0033575114     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.12.1051     Document Type: Article

References (46)

1. Young JL, Percy C, Asire AM. Surveillance, epidemiology and end results: incidence and mortality data: 1973-77. Natl Cancer Inst Monogr 1981;57:1-1082.
2. Devesa SS, Silverman DT, Young JL Jr, Pollack ES, Brown CC, Horm JH, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 1987;79:701-70.
3. Linet MS, Devesa SS. Descriptive epidemiology of childhood leukaemia. Br J Cancer 1991; 63:424-9.
4. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-82.
5. Miller RW, Young JL Jr, Novakovic B. Childhood cancer. Cancer 1995;75(1 Suppl): 395-405.
6. Bunin GR, Feuer EJ, Witman PA, Meadows AT. Increasing incidence of childhood cancer: report of 20 years experience from the Greater Delaware Valley Pediatric Tumor Registry. Paediatr Perinat Epidemiol 1996;10:319-38.
7. Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL. Trends in cancer incidence among children in the U.S. Cancer 1996; 78:532-41.
8. Ries LA, Kosary C, Hankey B, Miller B, Harras A, Edwards BK, editors. SEER cancer statistics review: 1973-95. Bethesda (MD): National Cancer Institute; 1998.
9. Smith MA, Freidlin B, Ries LA, Simon R. Trends in the reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998;90: 1269-77.
10. Cushman J. U.S. reshaping cancer strategy as incidence in children rises: increase may be tied to new chemicals in environment. The New York Times 1997. A1.
11. Kramarova E, Stiller CA. The International Classification of Childhood Cancer, Int J Cancer 1996;68:759-65.
12. Percy C, Van Holten V, Muir C, editors. International Classification of Diseases for Oncology. 2nd ed. Geneva (Switzerland ): World Health Organization, 1992.
13. Miller RW, Myers MH. Age distribution of epithelial and non-epithelial cancers. Lancet 1983;2:1250.
14. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer 1987;40: 620-4.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Hematol 1976;33:451-8.
16. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR. et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:460-2.
17. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103: 620-5.
18. Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AMLMO). Br J Haematol 1991;78:325-9.
19. Rorke LB, Gilles FH, Davis RL, Becker LE. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 1985;56(7 Suppl): 1869-86.
20. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68.
21. World Health Organization (WHO). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Vol. 1. Ninth revision, Geneva (Switzerland): WHO; 1977.
22. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames (IA): Iowa State University Press; 1980. p. 149-57.
23. Steinberg EP. The status of MRI in 1986: rates of adoption in the United States and worldwide. AJR Am J Roentgenol 1986;147:453-5.
24. Moore RM Jr, Jeng LL, Kaczmarek RG, Placek PJ. Use of diagnostic imaging procedures and fetal monitoring devices in the care of pregnant women. Public Health Rep 1990;105:471-5.
25. Miller RW. Childhood leukemia and neonatal exposure to lighting in nurseries. Cancer Causes Control 1992;3:581-2.
26. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75:2186-95.
27. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL. editors. International incidence of childhood cancer. IARC Scientific Publication 87. Lyon (France): International Agency for Research on Cancer; 1988.
28. Draper GJ, Kroll ME, Stiller CA. Childhood cancer. Cancer Surv 1994;19-20:493-517.
29. Blair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children: I. Leukaemia and lymphoma. Eur J Cancer 1994;30A:1490-98.
30. Blair V, Birch JM. Patterns and temporal trends in the incidence of malignant disease in children: II. Solid tumours of childhood. Eur J Cancer 1994;30A:1498-511.
31. Stroink AR. Hoffman HJ, Hendrick EB, Humphreys RP. Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 1986; 65:745-50.
32. Murphy SB, Cohn SL, Craft AW, Woods WG, Sawada T, Castleberry RP, et al. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet 1991;337:344-46.
33. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. Infant cancer in the U.S.: histology-specific incidence and trends, 1973-1992. J Pediatr Hematol Oncol 1997;19: 428-32.
34. Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM. Brisson LC, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996;348: 1682-7.
35. Yamamoto K, Hayashi Y, Hanada R, Kikuchi A, Ichikauwa M, Tanimura M, et al. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. J Clin Oncol 1995;53:2033-38.
36. Acharya SS, Jayabose S, Kogan SJ, Tugal O, Beneck D, Leslie D, et al. Prenatally diagnosed neuroblastoma. Cancer 1997;80:304-10.
37. Hoehner JC, Hedborg F, Eriksson L, Sandstedt B, Grimelius L, Olsen L, et al. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 1998;78:29-45.
38. Carlsen NL. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening. J Pediatr Hematol Oncol 1992;14:103-10.
39. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia (PA): Lippincott; 1993. p. 139-767.
40. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994;19-20:219-40.
41. Shmookler BM, Enzinger FM, Weiss SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 1989; 64:2154-61
42. Pedeutour F, Lacour JP, Perrin C, Huffermann K, Simon MP, Ayraud N, et al. Another case of t(17;22)(q22;q13) in an infantile dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 1996;89:175-6.
43. Martinsson U, Glimelius B, Sundstrom C. Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol 1992;31:275-82.
44. Hartge P, Devesa SS, Fraumeni JF Jr. Hodgkin's and non-Hodgkin's lymphomas. Cancer Surv 1994;19-20:423-53.
45. Mueller NE. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 2nd ed. New York (NY): Oxford University Press; 1996. p. 893-919.
46. Holford TR, Zheng T, Mayne ST, McKay LA. Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res 1992;52:5443s-5446s.